We next investigated the levels of LSM1 expression in different glioma subtypes based on histological type, WHO grade, age, IDH status, and 1p/19q codeletion, which demonstrate the significant elevation of LSM1 expression in specific glioma subgroups (Figure 2). The gene discussed is LSM1; the disease is central nervous system cancer.